Benitec’s Investigational Drug for Hepatitis B Shows Promise in Mouse Model
News
Benitec Biopharma recently announced that a single injection of its investigational drug BB-HB-331, a DNA-directed RNA interference (ddRNAi) therapy targeting the hepatitis B virus (HBV), displays a robust and durable ... Read more